Profiel
Rosh Chandraratna is the founder of Io Therapeutics, Inc. Former positions include Director & Chief Scientific Officer at NuRx Pharmaceuticals, Inc. from 2007 to 2009, Vice President-Retinoid Research at Allergan, Inc. in 2004, Senior Vice President-Research & Development at Vitae Pharmaceuticals LLC from 2004 to 2006, and Senior Vice President-Research & Development at Acucela, Inc. from 2006 to 2007.
Eerdere bekende functies van Rosh Chandraratna
| Bedrijven | Functie | Einde |
|---|---|---|
| NURX PHARMACEUTICALS INC | Hoofd Techniek/Wetenschap/O&O | 03-10-2009 |
| ACUCELA INC | Hoofd Techniek/Wetenschap/O&O | 01-05-2007 |
| VITAE PHARMACEUTICALS INC | Hoofd Techniek/Wetenschap/O&O | 01-09-2006 |
| ALLERGAN, INC. | Hoofd Techniek/Wetenschap/O&O | 01-05-2004 |
Io Therapeutics, Inc.
Io Therapeutics, Inc. BiotechnologyHealth Technology Develops retinoid and rexinoid molecule drugs for treatment of cancer | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Io Therapeutics, Inc.
Io Therapeutics, Inc. BiotechnologyHealth Technology Develops retinoid and rexinoid molecule drugs for treatment of cancer | Health Technology |
Vitae Pharmaceuticals LLC
Vitae Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops small molecule compounds | Health Technology |
Acucela, Inc.
Acucela, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
NuRx Pharmaceuticals, Inc.
NuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
















